Finding 1075644 (2023-006)

Material Weakness Repeat Finding
Requirement
C
Questioned Costs
-
Year
2023
Accepted
2024-09-27

AI Summary

  • Core Issue: Funding requests for contracts lacked proper review and approval, violating requirements for reimbursement.
  • Impacted Requirements: Requests must be based on actual costs and reviewed by knowledgeable staff to ensure compliance.
  • Recommended Follow-up: Implement stronger policies and controls to ensure all funding requests are properly reviewed and approved.

Finding Text

Federal Agency: U.S. Department of Health and Human Services Pass-through Agency: State of Connecticut, Department of Mental Health and Addiction Services (COVID-19) Commonwealth of Pennsylvania, Department of Drug and Alcohol Programs State of Louisiana, Department of Mental Health and Substance Abuse Services State of Oklahoma, Department of Mental Health and Substance Abuse Services Program Name (Assistance listing #): Block Grants for Prevention and Treatment of Substance Abuse (93.959) Criteria: Funding requests for cost reimbursement contracts must be based on actual costs incurred prior to reimbursement request. For funding requests made in advance of related expenditures, requests must be in amounts that minimize the time between cash receipt and when the funds are spent. Review of funding requests must be performed by an employee with knowledge of the government contract and of the funding needs of the federal program. Statement of Condition: For all selected sampled contracts under the advance payment method, there was no evidence of review and approval of the funding requests submitted. Cause: Procedures and internal controls associated with the preparation of funding requests were not adequately documented. Effect: Management did not have sufficient documentation for the funding requests submitted for government contract. Questioned Costs: None Perspective Information: The sampling was a statistically valid sample and represents a systemic issue. Identification of Repeat Finding: This finding is a repeat of Finding 2022-003. Recommendation: We recommend that management implement policies, controls and procedures to evidence review and approval of all funding requests from government contracts to comply with applicable cash management requirements. Views of Responsible Officials: Management is in agreement with the finding. Management is in the process of implementing additional policies, procedures and controls over the preparation, review and approval of funding requests submitted for government contracts.

Categories

Cash Management

Other Findings in this Audit

  • 499190 2023-004
    Material Weakness Repeat
  • 499191 2023-004
    Material Weakness Repeat
  • 499192 2023-004
    Material Weakness Repeat
  • 499193 2023-004
    Material Weakness Repeat
  • 499194 2023-004
    Material Weakness Repeat
  • 499195 2023-004
    Material Weakness Repeat
  • 499196 2023-004
    Material Weakness Repeat
  • 499197 2023-005
    Material Weakness
  • 499198 2023-006
    Material Weakness Repeat
  • 499199 2023-006
    Material Weakness Repeat
  • 499200 2023-006
    Material Weakness Repeat
  • 499201 2023-006
    Material Weakness Repeat
  • 499202 2023-006
    Material Weakness Repeat
  • 499203 2023-006
    Material Weakness Repeat
  • 499204 2023-006
    Material Weakness Repeat
  • 499205 2023-007
    Material Weakness
  • 499206 2023-008
    Significant Deficiency Repeat
  • 499207 2023-008
    Significant Deficiency Repeat
  • 499208 2023-008
    Significant Deficiency Repeat
  • 499209 2023-008
    Significant Deficiency Repeat
  • 499210 2023-008
    Significant Deficiency Repeat
  • 499211 2023-008
    Significant Deficiency Repeat
  • 499212 2023-008
    Significant Deficiency Repeat
  • 499213 2023-009
    Significant Deficiency
  • 1075632 2023-004
    Material Weakness Repeat
  • 1075633 2023-004
    Material Weakness Repeat
  • 1075634 2023-004
    Material Weakness Repeat
  • 1075635 2023-004
    Material Weakness Repeat
  • 1075636 2023-004
    Material Weakness Repeat
  • 1075637 2023-004
    Material Weakness Repeat
  • 1075638 2023-004
    Material Weakness Repeat
  • 1075639 2023-005
    Material Weakness
  • 1075640 2023-006
    Material Weakness Repeat
  • 1075641 2023-006
    Material Weakness Repeat
  • 1075642 2023-006
    Material Weakness Repeat
  • 1075643 2023-006
    Material Weakness Repeat
  • 1075645 2023-006
    Material Weakness Repeat
  • 1075646 2023-006
    Material Weakness Repeat
  • 1075647 2023-007
    Material Weakness
  • 1075648 2023-008
    Significant Deficiency Repeat
  • 1075649 2023-008
    Significant Deficiency Repeat
  • 1075650 2023-008
    Significant Deficiency Repeat
  • 1075651 2023-008
    Significant Deficiency Repeat
  • 1075652 2023-008
    Significant Deficiency Repeat
  • 1075653 2023-008
    Significant Deficiency Repeat
  • 1075654 2023-008
    Significant Deficiency Repeat
  • 1075655 2023-009
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $4.58M
93.788 Opioid Str $364,943
93.959 Block Grants for Prevention and Treatment of Substance Abuse $235,860
95.010 Congressional Directives $130,281